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Objectives This study was designed to compare the long-term clinical outcome of coronary artery bypass grafting (CABG)
with intracoronary stenting of patients with isolated proximal left anterior descending coronary artery.
Background Although numerous trials have compared coronary angioplasty with bypass surgery, none assessed the clinical
evaluation in the long term.
Methods We evaluated the 10-year clinical outcome in the SIMA (Stent versus Internal Mammary Artery grafting) trial.
Patients were randomly assigned to stent implantation versus CABG.
Results Of 123 randomized patients, 59 underwent CABG and 62 received a stent (2 patients were excluded). Follow-up
after 10 years was obtained for 98% of the randomized patients. Twenty-six patients (42%) in the percutaneous
coronary intervention group and 10 patients (17%) in the CABG group reached an end point (p  0.001). This
difference was due to a higher need for additional revascularization. The incidences of death and myocardial
infarction were identical at 10%. Progression of the disease requiring additional revascularization was rare (5%)
and was similar for the 2 groups. Stent thrombosis occurred in 2 patients (3%). Angina functional class showed
no significant differences between the 2 groups.
Conclusions Both stent implantation and CABG are safe and highly effective in relieving symptoms in patients with isolated, proxi-
mal left anterior descending coronary artery stenosis. Stenting with bare-metal stents is associated with a higher
need for repeat interventions. The long-term prognosis for these patients is excellent with either mode of
revascularization. (J Am Coll Cardiol 2008;52:815–7) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.05.037m
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The SIMA (Stent versus Internal Mammary Artery graft-
ng) prospective randomized trial compared clinical out-
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ercutaneous transluminal coronary angioplasty with bare-
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008, accepted May 27, 2008.etal stent implantation (percutaneous coronary interven-
ion [PCI]) in patients with isolated proximal left anterior
escending (LAD) coronary artery. After 2.4 years of
ollow-up, overall survival and incidence of myocardial
nfarction was similar for the 2 strategies (1). Data on
ong-term follow-up after PCI and internal mammary
rafting for single-vessel disease are scarce (2). The SIMA
rial data provides a unique opportunity to study these issues
n a very homogenous group of patients.
ethods
he SIMA trial enrolled 123 patients (at 6 European sites)
o be treated with either stent implantation or CABG for
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Stenting Versus Surgery for Proximal LAD Stenosis September 2, 2008:815–7isolated proximal LAD stenosis
and left ventricular ejection frac-
tion 45%. Follow-up was con-
ducted until all patients had
reached their 10-year follow-up.
The primary composite end
point was all causes of death,
myocardial infarction, and the
need for additional revasculariza-
tion. A secondary end point was
ngina functional class. These end points were evaluated at
and 10 years.
During the first 6 months after the procedure, patients
ere seen by the referring physician, who obtained the
istory and performed a physical examination. Noninvasive
ssessment was performed with a yearly stress test or cardiac
cintigraphy. Additional revascularization was left to the
iscretion of the treating cardiologist in patients with
ymptomatic or silent ischemia.
tatistical analysis. All analyses were made according to
he intention-to-treat principle. Continuous variables were
xpressed as mean  SD and discrete variables as counts
nd percentage. The event-free survival was estimated by
he Kaplan-Meier method and compared by a log-rank test.
tatistical significance was assigned at the p  0.05 level.
nly the most serious adverse event per patient was
eported.
esults
total of 123 patients met the inclusion criteria, but 2
atients were excluded. Thus, 121 patients were finally
ncluded. Baseline clinical and angiographic characteristics
f both groups were similar. At 1 month there was no
ifference, with 4% of adverse events in the CABG group
PCI
CABG
p  = 0.0004
Log rank test: 
p  = 0.9
PCI
CABG
Figure 1 Event-Free Survival Curves
Event-free survival curves for death and myocardial infarction for percutaneous
coronary intervention (PCI) (red) and coronary artery bypass grafting (CABG)
(black) (p  0.9) and event-free survival curves for death, myocardial infarc-
tion, and additional revascularization for PCI (green) and CABG (yellow) (p 
0.0004).
Abbreviations
and Acronyms
CABG  coronary artery
bypass grafting
LAD  left anterior
descending
PCI  percutaneous
coronary interventionrersus 7% in the PCI group (p  NS). At 10 years, a
rimary end point was reached more frequently in the PCI
roup than in the CABG group (Fig. 1). Mortality and
yocardial infarction rates were not statistically different
etween the 2 groups (Fig. 1). Five patients died after PCI
8%) and 4 patients after CABG (7%). The cause of death
as cardiac in 2 patients after PCI and in 1 patient after
ABG. Myocardial infarction (including those of the
eriprocedural period) occurred in 3 patients in both groups
4%). Stent thrombosis occurred in 2 patients (3%), 1 acute
nd 1 late; both patients suffered fatal acute myocardial
nfarction.
Significantly more patients assigned to PTCA required
dditional revascularization (18 patients [30%] vs. 3
atients [5%]). Revascularization of the LAD was re-
uired in 15 patients in the PCI group (25%) compared
ith none in the CABG group (p  0.001). Finally, 8
atients from the PCI group underwent CABG as an
dditional revascularization procedure. The incidence of
on-LAD revascularization was similar, with 3 patients
n both groups (5%) (Table 1). At 10 years, most of the
atients in both groups were asymptomatic (93%) or
uffered mild angina (7%). A majority of patients received
ntiplatelet therapy (94% PCI and 96% CABG). Rates of
ipid-lowering therapy increased gradually from 24% at 2
ears to 89% (88% PCI and 91% CABG) at 10 years.
eta-blockers, angiotensin-converting enzyme inhibitors,
nd calcium antagonists were given to more than 50% of
he patients without differences between the 2 groups.
reatment varied significantly during follow-up.
iscussion
his study provides information on long-term results for
revascularization strategies and disease progression in a
ery homogenous group of patients. The data confirm
hat the only difference between stenting and left internal
ammary artery grafting is in the need for additional
evascularization early after the intervention. The rela-
ively high incidence of restenosis and target lesion
dverse Events at 10 Years
Table 1 Adverse Events at 10 Years
Stent
(n  62)
CABG
(n  59) p Value
Death 5 4 0.4
Cardiac death 2 1
Noncardiac death 3 3
Q-wave MI 0 1 0.9
Non–Q-wave MI 3 2
TLR 13 0 0.0001
TVR 2 0
Non-LAD PTCA 3 3
Any event 26 (42%) 10 (17%) 0.0001
ABG  coronary artery bypass grafting; LAD  left anterior descending; MI  myocardial
nfarction; PTCA  percutaneous transluminal coronary angioplasty; TLR  target lesion revascu-
arization; TVR  target vessel revascularization.evascularization is consistent with isolated LAD artery
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zed to CABG required a second revascularization of the
AD. Our study results confirm the excellent outcome
fter CABG using this type of graft, which has been
hown to remain patent in more than 95% of patients at
 years (5). The PCI was followed by a higher rate of
eintervention. The use of drug-eluting stents might
inimize this difference between percutaneous and sur-
ical strategies (6). There are no prospective controlled
ata comparing proximal LAD stenting with drug-
luting stents with CABG, but in 1 matched cohort
bservation, there was a surprisingly high incidence of
eintervention after drug-eluting stent implantation (7).
urthermore, the incidence and impact of very late
rug-eluting stent thrombosis remains unknown and
akes it difficult to draw conclusions on whether long-
erm results with drug-eluting stents would compare
avorably to the outcome in our study.
The SIMA trial long-term data provide valuable infor-
ation about disease progression in single-vessel disease
eceiving secondary medical prevention with antiplatelet
gents and statins. The use of statins increased dramatically
rom 30% to 90% at 10 years. There is a strikingly low
ncidence of clinical adverse events attributable to disease
rogression, as only 5% of our patients required additional
on-LAD revascularization. This is important information
ecause use of mammary grafting is often delayed in young
atients because of the feared need for further operations.
tudy limitations. Our study describes a small cohort of
ighly selected patients; therefore, conclusions should not Ke applied to other types of lesions and patients. Stents used
n the SIMA study were first-generation bare-metal stents.
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